EPISODE · Nov 16, 2022 · 25 MIN
ATA188 ‘Game Changing’ for Progressive MS & Ublituximab Superior to Aubagio
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news report on ATA188, a treatment targeting the Epstein-Barr virus which could be integral in treating progressive MS.He also reads a news article reporting on how ublituximab works better than Aubagio at easing disability in patients with relapsing MS.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
NOW PLAYING
ATA188 ‘Game Changing’ for Progressive MS & Ublituximab Superior to Aubagio
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m